NYMOX PHARMACEUTICAL CORP (NYMXF) SEC Filings & Financials

About NYMOX PHARMACEUTICAL CORP

In Vitro & In Vivo Diagnostic Substances

NYMOX PHARMACEUTICAL CORP is classified under In Vitro & In Vivo Diagnostic Substances. Fiscal year ends on December 31.

Headquarters9900 CAVENDISH BLVD., SUITE 306
ST. LAURENT
QUEBEC CANADA, A8 H4M 2V2

Business AddressSame as mailing

Price Action (NYMXF)

No price bars found

Revenue and net income trend from consolidated statements.

Financial Performance